INOVIO Expands Partnership with Advaccine to Conduct Global Phase 3 Efficacy Trial of COVID-19 DNA Vaccine Candidate, INO-4800PRNewsWire • 06/08/21
Geneos Therapeutics Announces Clinical Updates on Personalized Cancer Vaccine ProgramPRNewsWire • 06/03/21
INOVIO Pharmaceuticals, Inc. (INO) CEO Joseph Kim Presents at Jefferies 2021 Virtual Healthcare Conference (Transcript)Seeking Alpha • 06/01/21